Exploring the breakthrough immunotherapy flotetuzumab for relapsed/refractory acute myeloid leukemia (AML) - mechanism, clinical trial results, and future directions.
Explore how single-cell proteomics is revolutionizing our understanding of Acute Myeloid Leukemia by revealing cellular heterogeneity and treatment resistance mechanisms.
Exploring the dangerous transformation of Chronic Myelomonocytic Leukemia into an aggressive form of Acute Myeloid Leukemia and the modern fight to improve outcomes.